Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-11-21

Clinical Trial Update: The Use of the CUE1/CUE1+ in People With Parkinson's Disease and Related Disorders [NA]

View source ↗

Summary

This entry provides an update on a clinical trial evaluating CUE1 and CUE1+ in people with Parkinson's disease and related disorders; recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CUE1

Snippet

Sponsor: Queen Mary University of London | Conditions: Parkinson's Disease and Parkinsonism, Progressive Supranuclear Palsy | NA | Status: RECRUITING